3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
17
Thoracic
1
Sarcoma
1
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
NET
1
Myeloid
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Gastrointestinal
1
Endocrine
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Ovarian Neoplasms
45
Uterine Cervical Neoplasms
21
Fallopian Tube Neoplasms
20
Carcinoma, Ovarian Epithelial
15
Neoplasms
8
Endometrial Neoplasms
8
Lung Neoplasms
7
Breast Neoplasms
5
Stomach Neoplasms
4
Recurrence
4
Pancreatic Neoplasms
4
Neoplasm Metastasis
4
Melanoma
4
Head and Neck Neoplasms
4
Gestational Trophoblastic Disease
4
Vulvar Neoplasms
3
Peritoneal Neoplasms
3
Kidney Neoplasms
3
Esophageal Neoplasms
3
Colorectal Neoplasms
3
Uterine Neoplasms
2
Sarcoma
2
Lymphoma, Non-Hodgkin
2
Liver Neoplasms
2
Laryngeal Neoplasms
2
Hydatidiform Mole
2
Gynecologic Cancer
2
Glioblastoma
2
Colonic Neoplasms
2
Cholangiocarcinoma
2
Interventions
pembrolizumab
14
Specimen Handling
8
Docetaxel
8
olaparib
7
Nivolumab
7
Gemcitabine
7
Trastuzumab
6
Paclitaxel
6
rucaparib
5
Magnetic Resonance Spectroscopy
5
Early Intervention, Educational
5
Biopsy
5
Standard of Care
4
Cyclophosphamide
4
Carboplatin
4
tisotumab vedotin
3
talazoparib
3
pertuzumab
3
durvalumab
3
atezolizumab
3
Taxes
3
Surveys and Questionnaires
3
Sirolimus
3
Radiotherapy
3
Psychiatric Rehabilitation
3
Methods
3
Irinotecan
3
Immunoglobulin G
3
Fulvestrant
3
Educational Status
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Prostatic Neoplasms
×
Drug Therapy
×
Gynecologic
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled